Why is Kobo Biotech falling/rising?

As of 20-Oct, Kobo Biotech Ltd's stock price is currently at 2.74, reflecting an increase of 0.11 or 4.18%. The stock has been on a positive trajectory, gaining for the last four days and achieving a total return of 14.64% during this period. Additionally, it has outperformed its sector by 3.62%. The stock's performance over the past week shows a significant increase of 14.17%, while the one-month return stands at 21.78%. Although the stock has underperformed over the longer term, with a one-year decline of 7.74% and a three-year decline of 47.10%, the recent uptick in delivery volume, which rose by 42.04% against the five-day average, indicates rising investor participation. There is no information available regarding positive or negative factors that could further explain the stock's recent movement.
Broader market context reveals that while Kobo Biotech has shown strong short-term performance, it has significantly outperformed the benchmark Sensex, which increased by only 2.47% over the same one-week period. This contrast highlights the stock's recent strength in a generally stable market environment. The Sensex's one-month return of 2.10% further emphasizes Kobo Biotech's robust performance relative to the broader market. Despite the stock's long-term struggles, the current momentum suggests a potential recovery phase, supported by increased trading activity and investor interest.